Free Trial

ENDRA Life Sciences (NDRA) Competitors

ENDRA Life Sciences logo
$6.48 -0.33 (-4.85%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$6.34 -0.14 (-2.16%)
As of 10/10/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NDRA vs. ICU, NXL, IINN, HSDT, ALUR, CTCX, BTCY, CODX, CHEK, and XAIR

Should you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include SeaStar Medical (ICU), Nexalin Technology (NXL), Inspira Technologies OXY B.H.N. (IINN), Helius Medical Technologies (HSDT), Allurion Technologies (ALUR), Carmell (CTCX), Biotricity (BTCY), Co-Diagnostics (CODX), Check-Cap (CHEK), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry.

ENDRA Life Sciences vs. Its Competitors

ENDRA Life Sciences (NASDAQ:NDRA) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

ENDRA Life Sciences has a beta of -0.09, suggesting that its share price is 109% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.07, suggesting that its share price is 207% less volatile than the S&P 500.

ENDRA Life Sciences has a net margin of 0.00% compared to SeaStar Medical's net margin of -1,915.27%. SeaStar Medical's return on equity of 0.00% beat ENDRA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ENDRA Life SciencesN/A -194.14% -127.89%
SeaStar Medical -1,915.27%N/A -232.65%

In the previous week, ENDRA Life Sciences and ENDRA Life Sciences both had 2 articles in the media. ENDRA Life Sciences' average media sentiment score of 0.95 equaled SeaStar Medical'saverage media sentiment score.

Company Overall Sentiment
ENDRA Life Sciences Positive
SeaStar Medical Positive

1.2% of ENDRA Life Sciences shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 0.0% of ENDRA Life Sciences shares are held by insiders. Comparatively, 1.3% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

ENDRA Life Sciences has higher earnings, but lower revenue than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ENDRA Life SciencesN/AN/A-$11.51M-$33.89-0.19
SeaStar Medical$140K113.99-$24.83M-$2.62-0.22

ENDRA Life Sciences currently has a consensus target price of $50.00, indicating a potential upside of 671.60%. Given ENDRA Life Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe ENDRA Life Sciences is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ENDRA Life Sciences
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

ENDRA Life Sciences beats SeaStar Medical on 8 of the 13 factors compared between the two stocks.

Get ENDRA Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NDRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NDRA vs. The Competition

MetricENDRA Life SciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$5.13M$7.00B$6.11B$10.63B
Dividend YieldN/A1.16%5.67%4.71%
P/E Ratio-0.1926.2985.3526.57
Price / SalesN/A192.73613.06132.61
Price / CashN/A22.0238.5062.09
Price / Book1.365.1112.746.53
Net Income-$11.51M$178.04M$3.30B$276.14M
7 Day Performance12.70%-2.10%0.82%-0.84%
1 Month Performance43.05%5.62%6.22%3.58%
1 Year Performance-11.84%23.63%80.30%37.16%

ENDRA Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NDRA
ENDRA Life Sciences
1.6995 of 5 stars
$6.48
-4.8%
$50.00
+671.6%
-15.8%$5.13MN/A-0.1920Analyst Forecast
High Trading Volume
ICU
SeaStar Medical
0.4925 of 5 stars
$0.59
-2.2%
N/A-85.5%$16.83M$766K-0.232Analyst Forecast
NXL
Nexalin Technology
2.7739 of 5 stars
$0.92
-3.1%
$5.00
+442.9%
+101.3%$16.25M$174.81K-1.213News Coverage
Analyst Forecast
IINN
Inspira Technologies OXY B.H.N.
2.4181 of 5 stars
$1.28
+0.4%
$2.00
+56.9%
-16.9%$16.09MN/A0.0020News Coverage
Analyst Forecast
Analyst Revision
HSDT
Helius Medical Technologies
1.181 of 5 stars
$14.67
+1.8%
N/A-96.0%$15.76M$520K-0.0130Trending News
Analyst Forecast
Gap Down
ALUR
Allurion Technologies
2.3311 of 5 stars
$2.02
+2.8%
$22.83
+1,033.2%
-88.7%$15.63M$32.11M-0.16501Analyst Forecast
CTCX
Carmell
N/A$0.74
-17.8%
N/A+98.6%$15.47M$32.84K0.0014Gap Down
BTCY
Biotricity
N/A$0.54
-8.5%
N/A+127.3%$14.43M$12.06M-0.5040Gap Up
CODX
Co-Diagnostics
4.4574 of 5 stars
$0.37
-0.6%
$5.50
+1,394.6%
-70.2%$14.25M$3.91M-0.32100Analyst Forecast
Gap Up
CHEK
Check-Cap
0.2149 of 5 stars
$2.35
+0.4%
N/A+24.3%$13.75MN/A-0.7880Positive News
Analyst Forecast
Gap Up
XAIR
Beyond Air
4.2049 of 5 stars
$2.42
-1.2%
$11.00
+354.4%
-61.6%$12.63M$3.70M-0.2070Positive News

Related Companies and Tools


This page (NASDAQ:NDRA) was last updated on 10/11/2025 by MarketBeat.com Staff
From Our Partners